The End Brain Cancer Initiative Partners with Pacific Marine Biotech for Glioblastoma Brain Cancer Trial of Immune12
A Phase 2 clinical trial of investigational product Immune12 is enrolling patients with GBM brain cancer to support marketing authorization in Australia. SEATTLE, WA, UNITED STATES, April 30, 2026 /EINPresswire.com/ -- The End Brain Cancer Initiative ( …